The novel approach of this peptide represents a significant advance in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide affects dual pathways – GLP-1 and GIP – providing greater blood https://tirzepatidepeptide410831.bcbloggers.com/40820602/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment